Oxypara-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (10mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to inhibit prostaglandin production, complementing the anti-inflammatory action of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators, promoting the reduction of swelling and enhancing tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries such as sprains and strains. Oxypara-SP offers rapid and sustained relief from pain and inflammation, improving patient mobility and quality of life. It is generally well-tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. The medication should be used under medical supervision, with adherence to prescribed dosages to minimize adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic enzyme alterations. Oxypara-SP Tablet represents an effective therapeutic option for multimodal pain management.